UBS Group’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.1M Sell
531,441
-100,250
-16% -$3.61M ﹤0.01% 1885
2025
Q1
$24.9M Sell
631,691
-15,406
-2% -$607K ﹤0.01% 1640
2024
Q4
$19.5M Sell
647,097
-18,858
-3% -$568K ﹤0.01% 1777
2024
Q3
$15.6M Buy
665,955
+145,723
+28% +$3.41M ﹤0.01% 1430
2024
Q2
$9.25M Sell
520,232
-4,390
-0.8% -$78.1K ﹤0.01% 1653
2024
Q1
$7.98M Sell
524,622
-40,214
-7% -$612K ﹤0.01% 1774
2023
Q4
$9.65M Buy
564,836
+209,271
+59% +$3.57M ﹤0.01% 1488
2023
Q3
$2.97M Buy
355,565
+210,173
+145% +$1.76M ﹤0.01% 2238
2023
Q2
$3.61M Sell
145,392
-121,488
-46% -$3.02M ﹤0.01% 2166
2023
Q1
$4.01M Sell
266,880
-188,887
-41% -$2.84M ﹤0.01% 2020
2022
Q4
$5.39M Buy
455,767
+433,782
+1,973% +$5.13M ﹤0.01% 1782
2022
Q3
$131K Sell
21,985
-113,366
-84% -$676K ﹤0.01% 4434
2022
Q2
$576K Sell
135,351
-18,572
-12% -$79K ﹤0.01% 3260
2022
Q1
$1.46M Sell
153,923
-99,869
-39% -$950K ﹤0.01% 2919
2021
Q4
$4.82M Buy
253,792
+172,501
+212% +$3.28M ﹤0.01% 2125
2021
Q3
$2.71M Buy
81,291
+74,994
+1,191% +$2.5M ﹤0.01% 2529
2021
Q2
$244K Sell
6,297
-41,303
-87% -$1.6M ﹤0.01% 4206
2021
Q1
$2.3M Buy
47,600
+39,630
+497% +$1.91M ﹤0.01% 2647
2020
Q4
$415K Sell
7,970
-579
-7% -$30.1K ﹤0.01% 3815
2020
Q3
$229K Buy
8,549
+2,122
+33% +$56.8K ﹤0.01% 3909
2020
Q2
$125K Sell
6,427
-61,456
-91% -$1.2M ﹤0.01% 4318
2020
Q1
$668K Buy
67,883
+33,383
+97% +$329K ﹤0.01% 2978
2019
Q4
$383K Sell
34,500
-240,699
-87% -$2.67M ﹤0.01% 4108
2019
Q3
$1.55M Buy
275,199
+59,606
+28% +$335K ﹤0.01% 2840
2019
Q2
$1.87M Buy
215,593
+190,407
+756% +$1.65M ﹤0.01% 2565
2019
Q1
$203K Sell
25,186
-339,197
-93% -$2.73M ﹤0.01% 3839
2018
Q4
$1.49M Buy
364,383
+323,887
+800% +$1.33M ﹤0.01% 2671
2018
Q3
$226K Buy
40,496
+3,559
+10% +$19.9K ﹤0.01% 4148
2018
Q2
$486K Sell
36,937
-166,923
-82% -$2.2M ﹤0.01% 3555
2018
Q1
$2.9M Buy
203,860
+128,766
+171% +$1.83M ﹤0.01% 2259
2017
Q4
$616K Sell
75,094
-40,365
-35% -$331K ﹤0.01% 3322
2017
Q3
$1.37M Buy
115,459
+96,960
+524% +$1.15M ﹤0.01% 2765
2017
Q2
$186K Buy
18,499
+3,893
+27% +$39.1K ﹤0.01% 3932
2017
Q1
$171K Buy
14,606
+3,736
+34% +$43.7K ﹤0.01% 3897
2016
Q4
$50K Buy
10,870
+3,873
+55% +$17.8K ﹤0.01% 4925
2016
Q3
$54K Sell
6,997
-793
-10% -$6.12K ﹤0.01% 4589
2016
Q2
$48K Sell
7,790
-4,114
-35% -$25.3K ﹤0.01% 4702
2016
Q1
$101K Sell
11,904
-63,280
-84% -$537K ﹤0.01% 4226
2015
Q4
$897K Buy
75,184
+57,113
+316% +$681K ﹤0.01% 2766
2015
Q3
$182K Buy
18,071
+11,471
+174% +$116K ﹤0.01% 3771
2015
Q2
$110K Sell
6,600
-500
-7% -$8.33K ﹤0.01% 4226
2015
Q1
$110K Sell
7,100
-1,385
-16% -$21.5K ﹤0.01% 4130
2014
Q4
$135K Buy
+8,485
New +$135K ﹤0.01% 4024